Global Health Ltd (ASX:GLH) has appointed Steven Strange, founder of aged care sector software provider Health Metrics (HM), as non-executive director.
Strange brings 30 years of leadership experience in the health industry to the board of directors.
Strange is a full member of the Australian Computer Society (MACS), member of the Australian Institute of Company Directors (MAICD) and holds computing and law qualifications from Monash University including a master’s degree in information science.
30 years of leadership experience
Strange was the founder and executive director of HM, a leading provider of software solutions to the aged care sector.
He also recently successfully completed the sale of HM to private equity interests.
Strange brings over 30 years of leadership experience to the board at Global Health at an opportune and pivotal time, where the company seeks to significantly grow its business both domestically and in its positioning in the Asia Pacific Region.
Sound understanding of health care models
The ongoing digitisation of the healthcare sector, fast-tracked by the worldwide pandemic, also highlights why the skillset of Strange will be a welcome addition to the board.
At HM, this experience was clearly demonstrated where Strange directed and oversaw the execution of HM’s global strategy.
Among other things, this involved taking technology products to local and international markets.
Via this process, Strange has developed a sound understanding of health care models, on a global basis.
“Sets Global Health up very well”
Global Health chairman Steven Pynt expressed his excitement at the appointment of Strange to the board of directors and said: “The Board of Global Health has always been characterised by a demonstrable depth of business, healthcare industry and worldly experience which enables easy access for the CEO and the leadership team to seek out and obtain excellent counsel at any time.
“The passing of the baton from Mr. Robert Knowles AO to Mr. Steven Strange is further evidence of this and sets Global Health up very well as part of its current growth cycle for the challenges ahead.”